clindamycin 0.02 MG/MG Vaginal Gel [Xaciato]
- RxCUI
- 2587815
- RxNorm name
- clindamycin 0.02 MG/MG Vaginal Gel [Xaciato]
- Display name
- clindamycin 0.02 MG/MG Vaginal Gel [Xaciato]
- Full name
- clindamycin 0.02 MG/MG Vaginal Gel [Xaciato]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:46
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| XACIATO | CLINDAMYCIN PHOSPHATE | Organon LLC | 0423007f-28fa-4159-bf58-9174626d2347 | 2026-02-19 | Warnings, Adverse reactions | 2587815 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 0423007f-28fa-4159-bf58-9174626d2347 | XACIATO 2 % Vaginal Gel [PSN] · clindamycin 0.02 MG/MG Vaginal Gel [Xaciato] [SBD] · Xaciato 0.02 MG/MG Vaginal Gel [SY] · Xaciato 2 % Vaginal Gel [SY] | 4 | 13 | These highlights do not include all the information needed to use XACIATO safely and effectively. See full prescribing information for XACIATO XACIATO ® (clindamycin phosphate) vaginal gel Initial U.S. Approval: 2021 | 20260219 |